Patents Assigned to NeuroEnergy Ventures, Inc.
  • Taste-Masking Formulation For Ketone Body Compounds
    Publication number: 20220338510
    Abstract: A taste-masking formulation for distasteful ketone body compounds is disclosed.
    Type: Application
    Filed: February 21, 2020
    Publication date: October 27, 2022
    Applicant: NeuroEnergy Ventures, Inc.
    Inventors: HOUSTON SMITH, BERNADITA P. DESIERTO, BEVERLY ANN SCHAD, DANIELLE LASOTA, SEAN WHITTEMORE
  • GLYCERYL TRIS (BETA-HYDROXYBUTYRATE) AND NEURONAL TRANSIENT ISCHEMIC ATTACKS
    Publication number: 20220288006
    Abstract: A method of use of Gylceryl Tris (Beta-hydroxybutyrate) in the minimization, reduction, or prevention of neuronal deficit and/or neuronal cell death with respect to follow-on neuronal transient ischemic attacks (NTIAs) in subjects who have had (or in subjects exhibiting symptomology of having had) at least one prior NTIA.
    Type: Application
    Filed: May 30, 2019
    Publication date: September 15, 2022
    Applicant: NeuroEnergy Ventures, Inc.
    Inventor: SAMI HASHIM
  • Taste-Masking Formulation For Ketone Body Compounds
    Publication number: 20220183327
    Abstract: A taste-masking formulation for distasteful ketone body compounds is disclosed.
    Type: Application
    Filed: February 21, 2020
    Publication date: June 16, 2022
    Applicant: NeuroEnergy Ventures, Inc.
    Inventors: HOUSTON SMITH, BERNADITA P. DESIERTO, BEVERLY ANN SCHAD, DANIELLE LASOTA, SEAN WHITTEMORE
  • Glyceryl 3-hydroxybutyrates for migraine symptom management
    Patent number: 10792269
    Abstract: A method of management of migraine symptom reduction and/or management and/or prophylaxis is disclosed using 3-hydroxybutyrate glycerides is disclosed.
    Type: Grant
    Filed: December 14, 2018
    Date of Patent: October 6, 2020
    Assignee: NeuroEnergy Ventures, Inc.
    Inventor: Sami Hashim
  • Glyceryl 3-hydroxybutyrates for traumatic brain injury
    Patent number: 10736867
    Abstract: A method of treatment of mild to moderate non-penetrating closed traumatic brain injury and mild to moderate TBI due to surgical intervention using 3-hydroxybutyate glycerides is disclosed.
    Type: Grant
    Filed: March 1, 2018
    Date of Patent: August 11, 2020
    Assignee: Neuroenergy Ventures, Inc.
    Inventor: Sami Hashim
  • GLYCERYL 3-HYDROXYBUTYRATES FOR MIGRAINE SYMPTOM MANAGEMENT
    Publication number: 20190117612
    Abstract: A method of management of migraine symptom reduction and/or management and/or prophylaxis is disclosed using 3-hydroxybutyrate glycerides is disclosed.
    Type: Application
    Filed: December 14, 2018
    Publication date: April 25, 2019
    Applicant: NeuroEnergy Ventures, Inc.
    Inventor: Sami Hashim
  • GLYCERYL 3-HYDROXYBUTYRATES FOR TRAUMATIC BRAIN INJURY
    Publication number: 20180193300
    Abstract: A method of treatment of mild to moderate non-penetrating closed traumatic brain injury and mild to moderate TBI due to surgical intervention using 3-hydroxybutyate glycerides is disclosed.
    Type: Application
    Filed: March 1, 2018
    Publication date: July 12, 2018
    Applicant: NeuroEnergy Ventures, Inc.
    Inventor: Sami Hashim
  • GLYCERYL 3-HYDROXYBUTYRATES FOR MIGRAINE SYMPTOM MANAGEMENT
    Publication number: 20180177753
    Abstract: A method of management of migraine symptom reduction and/or management and/or prophylaxis is disclosed using 3-hydroxybutyate glycerides is disclosed.
    Type: Application
    Filed: December 23, 2016
    Publication date: June 28, 2018
    Applicant: NeuroEnergy Ventures, Inc.
    Inventor: Sami Hashim
  • Glyceryl 3-hydroxybutyrates for traumatic brain injury
    Patent number: 9925164
    Abstract: A method of treatment of mild to moderate non-penetrating closed traumatic brain injury and mild to moderate TBI due to surgical intervention using 3-hydroxybutyate glycerides is disclosed.
    Type: Grant
    Filed: January 12, 2017
    Date of Patent: March 27, 2018
    Assignee: NeuroEnergy Ventures, Inc.
    Inventor: Sami Hashim